Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of the Performance of a cfDNA Methylation-based Model Combined With Serum Tumor Markers for Early Hepatobiliary Malignancies Detection

NCT04835675 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.

NCT NCT04835675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04835675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of the Performance of a cfDNA Methylation-based Model Combined With Serum Tumor Markers for Early Hepatobiliary Malignancies Detection
Lead sponsor
Zhujiang Hospital
Phase
Observational
Overall status
Completed
Start date
March 12, 2021
Completion date
June 30, 2022
Enrollment
496 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatobiliary malignancies